Evidence map›Paper›PMID 27067391›Full record

ArticleBMC medical genomics2016

A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.

Eliseos J Mucaki, Natasha G Caminsky, Ami M Perri, Ruipeng Lu, Alain Laederach, Matthew Halvorsen, Joan H M Knoll, Peter K Rogan

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Whole Exome Sequencing IdentifiesInternational journal of molecular sciences · 2021
    Trial
  2. Article
  3. Article
  4. Genes · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Non-Coding Variants inCancers · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Eliseos J MucakiDepartment of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 2C1, Canada.
Natasha G CaminskyDepartment of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 2C1, Canada.
Ami M PerriDepartment of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 2C1, Canada.
Ruipeng LuDepartment of Computer Science, Faculty of Science, Western University, London, N6A 2C1, Canada.
Alain LaederachDepartment of Biology, University of North Carolina, Chapel Hill, NC, 27599-3290, USA.
Matthew HalvorsenInstitute for Genomic Medicine, Columbia University Medical Center, New York, NY, 10032, USA.
Joan H M KnollDepartment of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, N6A 2C1, Canada.
Peter K RoganDepartment of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 2C1, Canada. progan@uwo.ca.
Western University · CAColumbia University Irving Medical Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Structural and functional consequences of disease SNPs on the transcriptomeR01GM101237 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAEDERACH, ALAIN T · 2012 to 2020
$2.5M
Predicting the causative SNPs in LD blocks by allele-specific structural analysisR01HG008133 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAEDERACH, ALAIN T, WEEKS, KEVIN M · 2015 to 2017
$2.4M
NHGRI NIH HHS R01 HG008133NIGMS NIH HHS R01 GM101237
6 · The paper itself

Abstract

backgroundSequencing of both healthy and disease singletons yields many novel and low frequency variants of uncertain significance (VUS). Complete gene and genome sequencing by next generation sequencing (NGS) significantly increases the number of VUS detected. While prior studies have emphasized protein coding variants, non-coding sequence variants have also been proven to significantly contribute to high penetrance disorders, such as hereditary breast and ovarian cancer (HBOC). We present a strategy for analyzing different functional classes of non-coding variants based on information theory (IT) and prioritizing patients with large intragenic deletions.

methodsWe captured and enriched for coding and non-coding variants in genes known to harbor mutations that increase HBOC risk. Custom oligonucleotide baits spanning the complete coding, non-coding, and intergenic regions 10 kb up- and downstream of ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, and TP53 were synthesized for solution hybridization enrichment. Unique and divergent repetitive sequences were sequenced in 102 high-risk, anonymized patients without identified mutations in BRCA1/2. Aside from protein coding and copy number changes, IT-based sequence analysis was used to identify and prioritize pathogenic non-coding variants that occurred within sequence elements predicted to be recognized by proteins or protein complexes involved in mRNA splicing, transcription, and untranslated region (UTR) binding and structure. This approach was supplemented by in silico and laboratory analysis of UTR structure.

results15,311 unique variants were identified, of which 245 occurred in coding regions. With the unified IT-framework, 132 variants were identified and 87 functionally significant VUS were further prioritized. An intragenic 32.1 kb interval in BRCA2 that was likely hemizygous was detected in one patient. We also identified 4 stop-gain variants and 3 reading-frame altering exonic insertions/deletions (indels).

conclusionsWe have presented a strategy for complete gene sequence analysis followed by a unified framework for interpreting non-coding variants that may affect gene expression. This approach distills large numbers of variants detected by NGS to a limited set of variants prioritized as potential deleterious changes.

Indexed as

Genetic Predisposition to DiseaseBase SequenceBreast NeoplasmsDNA, IntergenicExonsFemaleHumansInformation TheoryInheritance PatternsMolecular Sequence DataMutationNucleic Acid ConformationOvarian NeoplasmsPolymorphism, Single NucleotideProtein BindingProtein IsoformsDNA, IntergenicProtein IsoformsRNA Splice SitesUntranslated RegionsHereditary breast and ovarian cancerInformation theoryNext-generation sequencingNon-codingPrioritizationRNA-binding proteinSplicingTranscription factor bindingVariants of uncertain significance

Identifiers

PMID27067391
PMCPMC4828881
OpenAlexW2338488200

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.